# Dawah Pharmaceuticals, Inc. — Form D

Dawah Pharmaceuticals, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-15. The offering totals $10.0M, of which $580K was reported sold. Industry: Manufacturing.

## Offering

- Filed: 2019-10-15
- Form: D
- Accession: 0001738106-19-000003
- Industry: Manufacturing
- Exemptions: 06c
- Total offering: $10.0M
- Amount sold: $580K
- Remaining: $9.4M
- Minimum investment: $25K
- Investors: 6
- Date of first sale: 2018-03-19
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-351062

## Issuer

- Name: Dawah Pharmaceuticals, Inc.
- CIK: 0001738106
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 251 LITTLE FALLS DRIVE, WILMINGTON, DE, 19808
- Phone: 516-418-8058

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Maksoud Maksoud | Executive Officer | Hempstead, NY |

## More

- [CIK 1738106 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1738106&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001738106-19-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.